These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 10675585
1. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding. Goldman RC, Baizman ER, Longley CB, Branstrom AA. FEMS Microbiol Lett; 2000 Feb 15; 183(2):209-14. PubMed ID: 10675585 [Abstract] [Full Text] [Related]
2. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis. Goldman RC, Gange D. Curr Med Chem; 2000 Aug 15; 7(8):801-20. PubMed ID: 10828288 [Abstract] [Full Text] [Related]
3. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Ge M, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D. Science; 1999 Apr 16; 284(5413):507-11. PubMed ID: 10205063 [Abstract] [Full Text] [Related]
4. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry. Chang JD, Foster EE, Thadani AN, Ramirez AJ, Kim SJ. J Bacteriol; 2017 Aug 01; 199(15):. PubMed ID: 28507244 [Abstract] [Full Text] [Related]
5. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic. Allen NE, Hobbs JN, Nicas TI. Antimicrob Agents Chemother; 1996 Oct 01; 40(10):2356-62. PubMed ID: 8891144 [Abstract] [Full Text] [Related]
6. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin. Wu ZC, Boger DL. Acc Chem Res; 2020 Nov 17; 53(11):2587-2599. PubMed ID: 33138354 [Abstract] [Full Text] [Related]
7. Analysis of peptidoglycan precursors in vancomycin-resistant enterococci. Billot-Klein D, Gutmann L, Collatz E, van Heijenoort J. Antimicrob Agents Chemother; 1992 Jul 17; 36(7):1487-90. PubMed ID: 1510445 [Abstract] [Full Text] [Related]
8. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase. Baizman ER, Branstrom AA, Longley CB, Allanson N, Sofia MJ, Gange D, Goldman RC. Microbiology (Reading); 2000 Dec 17; 146 Pt 12():3129-3140. PubMed ID: 11101671 [Abstract] [Full Text] [Related]
10. On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari. Hammes WP, Neuhaus FC. Antimicrob Agents Chemother; 1974 Dec 16; 6(6):722-8. PubMed ID: 4451345 [Abstract] [Full Text] [Related]
11. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface. Rao J, Yan L, Lahiri J, Whitesides GM, Weis RM, Warren HS. Chem Biol; 1999 Jun 16; 6(6):353-9. PubMed ID: 10375541 [Abstract] [Full Text] [Related]
12. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues. Allen NE, LeTourneau DL, Hobbs JN. Antimicrob Agents Chemother; 1997 Jan 16; 41(1):66-71. PubMed ID: 8980756 [Abstract] [Full Text] [Related]
13. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type. Billot-Klein D, Shlaes D, Bryant D, Bell D, van Heijenoort J, Gutmann L. Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):711-5. PubMed ID: 8611145 [Abstract] [Full Text] [Related]
14. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum. Ferain T, Hobbs JN, Richardson J, Bernard N, Garmyn D, Hols P, Allen NE, Delcour J. J Bacteriol; 1996 Sep 01; 178(18):5431-7. PubMed ID: 8808932 [Abstract] [Full Text] [Related]
15. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall. Kwun MJ, Novotna G, Hesketh AR, Hill L, Hong HJ. Antimicrob Agents Chemother; 2013 Sep 01; 57(9):4470-80. PubMed ID: 23836175 [Abstract] [Full Text] [Related]
16. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. Billot-Klein D, Gutmann L, Bryant D, Bell D, Van Heijenoort J, Grewal J, Shlaes DM. J Bacteriol; 1996 Aug 01; 178(15):4696-703. PubMed ID: 8755902 [Abstract] [Full Text] [Related]
17. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus. Maki H, Miura K, Yamano Y. Antimicrob Agents Chemother; 2001 Jun 01; 45(6):1823-7. PubMed ID: 11353632 [Abstract] [Full Text] [Related]
18. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria. Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Isakova EB, Reznikova MI, Goldman RC, Branstrom AA, Baizman ER, Longley CB, Sztaricskai F, Batta G, Preobrazhenskaya MN. J Med Chem; 2002 Mar 14; 45(6):1340-7. PubMed ID: 11882003 [Abstract] [Full Text] [Related]
19. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Brötz H, Bierbaum G, Reynolds PE, Sahl HG. Eur J Biochem; 1997 May 15; 246(1):193-9. PubMed ID: 9210483 [Abstract] [Full Text] [Related]
20. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. Billot-Klein D, Gutmann L, Sablé S, Guittet E, van Heijenoort J. J Bacteriol; 1994 Apr 15; 176(8):2398-405. PubMed ID: 8157610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]